Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Gary Titus Insider Profile
4 Followers
Gary Titus, Director at ImmunoCellular Therapeutics, holds 28.00K shares in ImmunoCellular Therapeutics (Ticker: IMUC), holds 37.09K shares in Sciclone Pharmaceuticals (Ticker: SCLN), holds 2.63K shares in Arca Biopharma (Ticker: ABIO).
Profitable Transactions
5 out of 6 Profitable Transactions
Average Return
+35.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Gary Titus holds in companies
Most Profitable Insider Trade
Stock:
Sciclone Pharmaceuticals
(SCLN)
(SCLN)
Rating:Informative Buy
Date:May 26, 2009 - May 26, 2010
Return:+69.50%
The most profitable trade made by Gary Titus
Gary Titus's Trading History
ImmunoCellular Therapeutics
Sep 22, 2015
Director
Uninformative Buy
―
$5.04K
Sciclone Pharmaceuticals
Jun 18, 2012
―
Uninformative Buy
1.00K
$413.61K
Arca Biopharma
―
Chief Acct.Officer
―
$8.66K
List of latest transactions for each holding click on a transaction to see Gary Titus's performance on stock
You May Also Like
Gary Titus insider profile FAQ
What is the percentage of profitable transactions made by Gary Titus?
The percentage of profitable transactions made by Gary Titus is 83%.
What is the average return per transaction made by Gary Titus?
The average return per transaction made by Gary Titus is 35.60%.
What stocks does Gary Titus hold?
Gary Titus holds: IMUC, SCLN, ABIO stocks.
What was Gary Titus’s latest transaction?
Gary Titus latest transaction was an Uninformative Buy of ―.
What was Gary Titus's most profitable transaction?
Gary Titus’s most profitable transaction was an Informative Buy of SCLN stock on May 26, 2009. The return on the trade was 69.50%.
What is Gary Titus's role in ImmunoCellular Therapeutics?
Gary Titus's role in ImmunoCellular Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.